NCT01913652 2021-09-14Ph II Cabazitaxel DD LiposarcomaEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 2 Completed42 enrolled
NCT01740570 2018-01-19Phase I/II Cabazitaxel for Recurrent Malignant GliomaM.D. Anderson Cancer CenterPhase 1/2 Withdrawn